comparemela.com

Latest Breaking News On - Theseus pharmaceuticals trading down - Page 1 : comparemela.com

Q3 2023 EPS Estimates for Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Increased by Wedbush

Q3 2023 EPS Estimates for Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Increased by Wedbush
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Montreal
Quebec
Canada
Stifel-nicolaus
Carll-gordon
Institutional-investors-weigh-in-on-theseus-pharmaceuticals
Theseus-pharmaceuticals
Needham-company
Highvista-strategies
Theseus-pharmaceuticals-trading-down
Theseus-pharmaceuticals-inc
Cantor-fitzgerald

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Short Interest Up 25.2% in June

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report) saw a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 1,440,000 shares, an increase of 25.2% from the June 15th total of 1,150,000 shares. Currently, 9.5% of the company’s stock are short sold. Based on an […]

Stifel-nicolaus
Geode-capital-management
Theseus-pharmaceuticals
Nasdaq
Fairmount-funds-management
Needham-company
Theseus-pharmaceuticals-inc
Jpmorgan-chase-co
Cantor-fitzgerald
Institutional-investors-weigh-in-on-theseus-pharmaceuticals
News-ratings-for-theseus-pharmaceuticals-daily
Theseus-pharmaceuticals-trading-down

Theseus Pharmaceuticals (NASDAQ:THRX) Price Target Cut to $9.00 by Analysts at HC Wainwright

Theseus Pharmaceuticals (NASDAQ:THRX – Get Free Report) had its price objective dropped by stock analysts at HC Wainwright from $22.00 to $9.00 in a research report issued to clients and investors on Friday, FlyOnTheWall reports. HC Wainwright’s target price suggests a potential downside of 5.46% from the company’s previous close. Theseus Pharmaceuticals Trading Down 3.7 […]

United-states
American
Theseus-pharmaceuticals-inc
Deutsche-bank
Theseus-pharmaceuticals-trading-down
Institutional-investors-weigh-in-on-theseus-pharmaceuticals
Theseus-pharmaceuticals
American-international-group-inc
Charles-schwab-investment-management-inc
News-ratings-for-theseus-pharmaceuticals-daily
Tower-research-capital

Opaleye Management Inc. Acquires 314,350 Shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Opaleye Management Inc. grew its stake in shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Rating) by 142.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 535,000 shares of the company’s stock after buying an additional 314,350 shares during the period. Opaleye Management Inc.’s holdings in Theseus […]

United-states
American
America
Stifel-nicolaus
America-corp
Theseus-pharmaceuticals-company-profile
News-ratings-for-theseus-pharmaceuticals-daily
Theseus-pharmaceuticals-inc
Needham-company
Opaleye-management-inc
Theseus-pharmaceuticals-trading-down
American-international-group-inc

vimarsana © 2020. All Rights Reserved.